RSS

Brexit

The chief executive of the Association of the British Pharmaceutical Industry (ABPI) will tell the House of Commons DExEU Select Committee how they are preparing for a ‘No Deal’ Brexit. more

News

In her last Editor's Desk feature, Felicity Thomas analyses how Brexit is going to affect the pharma industry and what we can expect from the EMA and MHRA. more

News

In preparations for Brexit, the EMA has redistributed the UK’s product portfolio to other EU members and is not allocating any centralised marketing authorisation applications to the MHRA. We take a closer look… more

Opinion

The Wasdell Group — an outsourcing partner to companies in the pharma, medical device and clinical trials industries — has announced it will be opening a new facility in Dundalk, Ireland in Spring 2019 after a €30 million investment. more

News

Following a speech from the secretary of state, Dominic Raab, on the steps that government as well as business and the public sector should be taking in case of a ‘no-deal’ scenario for Brexit, we take a look at some of the responses from industry… more

News

We have now passed the six month point before the Falsified Medicines Directive (FMD) comes into force. In this online exclusive, Mark Davison, senior operations director, rfxcel insists you ACT NOW! Here are six short reflections. more

Opinion

The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. more

News

As Brexit edges nearer, the European Medicines Agency has revealed further temporary scale backs and suspension of activities as a result of higher than expected staff losses resulting from its move from London to Amsterdam. more

News

A new report from manufacturers’ organisation, EEF, and business advisory firm, BDO, has highlighted that strong performance by the UK’s manufacturing sector may be masking future concerns around future investment and trade. more

Analysis

Last week, the UK government saw heated debates and closely contested votes on the post-Brexit strategy, including a favourable outcome for the future relationship of the UK and the European Medicines Agency (EMA) more

News

A joint statement from the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) has been released in response to the publication of a government white paper more

News

Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter. more

Analysis

May and Trump

AL hutluht / Shutterstock.com

A black-tie dinner has been arranged for UK business leaders — including big pharma CEOs — and the US president, Donald Trump, to be hosted by the prime minister, Theresa May, according to an article published in the Financial Times (FT). more

News

In this online exclusive, Paul Brooks, executive director, Regulatory Affairs Professionals Society (RAPS), looks at the impact Brexit may have on the healthcare product regulatory space and how clarity is urgently needed. more

Opinion

The Association of the British Pharmaceutical Industry has issued a response to comments made by Simon Stevens — chief executive of NHS England — during his interview on the Andrew Marr show earlier this month. more

News

Digital freight forwarded, Zencargo, has stressed that inefficiencies in the supply chain are costing businesses in the UK £1.5 billion per year. more

Analysis

Now we have just passed the six-month marker (1 July) until the European Medicines Agency (EMA) moves from its current location in London to Amsterdam, as a result of Brexit, we gauge industry response to this change… more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

‘Doing nothing is not an option’ is the overriding message from pharmaceutical experts who attended the recent Pharmaceutical Industry Network Group (PING) seminar, held in conjunction with Ethical Medicines Industry Group (EMIG). more

News

A brief round-up of some of the developments in the industry including a step in the right direction for oral insulin and an overview of Alantra Pharma’s Fast 50 index… more

Opinion